RisdiplamPneumonia following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36745-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：348 / 348

相关论文

共 50 条

[21] SirolimusPneumonia following off-label use: case report
Reactions Weekly, 2020, 1800 (1) : 269 - 269
[22] GalcanezumabConstipation following off-label use: case report
Reactions Weekly, 2025, 2046 (1) : 169 - 169
[23] TolvaptanHypernatraemia following off-label use: case report
Reactions Weekly, 2019, 1753 (1) : 326 - 326
[24] InsulinHypoglycaemia following off-label use: case report
Reactions Weekly, 2021, 1843 (1) : 204 - 204
[25] MethylprednisoloneFungaemia following an off-label use: case report
Reactions Weekly, 2022, 1899 (1) : 243 - 243
[26] BevacizumabCataract following off-label use: case report
Reactions Weekly, 2019, 1747 (1) : 63 - 63
[27] SildenafilHypotension following off-label use: case report
Reactions Weekly, 2025, 2045 (1) : 376 - 376
[28] DaratumumabHypogammaglobulinemia following off-label use: case report
Reactions Weekly, 2020, 1802 (1) : 114 - 114
[29] DapsoneMethaemoglobinaemia following off-label use: case report
Reactions Weekly, 2021, 1843 (1) : 130 - 130
[30] NalbuphineBradycardia following an off-label use: case report
Reactions Weekly, 2019, 1753 (1) : 255 - 255

← 1 2 3 4 5 →